Company
Headquarters: New York, NY, United States
| Company | Market Cap (USD) |
|---|---|
| Blackstone | $148.37 B |
| BlackRock | $117.48 B |
| KKR & Co. Inc. | $97.78 B |
| Brookfield Corporation | $65.40 B |
| The Bank of New York Mellon Corporation | $44.78 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $887.16 B |
| JPMorgan | $599.29 B |
| Visa | $550.38 B |
| Mastercard | $416.63 B |
| Bank of America | $316.02 B |
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
DND Technologies, Inc. has the following listings and related stock indices.
Stock: OTC: DNDT wb_incandescent
Headquarters:
954 Lexington Avenue
Suite 505
New York, NY 10021
United States
Phone: 800 341 8940